Gilead Sciences's most recent trend suggests a bullish bias. One trading opportunity on Gilead Sciences is a Bull Put Spread using a strike $99.00 short put and a strike $94.00 long put offers a potential 27.55% return on risk over the next 31 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $99.00 by expiration. The full premium credit of $1.08 would be kept by the premium seller. The risk of $3.92 would be incurred if the stock dropped below the $94.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Gilead Sciences is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Gilead Sciences is bullish.
The RSI indicator is above 80 which suggests that the stock is in overbought territory.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Gilead Sciences
Amicus Therapeutics (FOLD) Worth Watching: Stock Rises 20.4%
Thu, 21 Aug 2014 10:35:39 GMT
hVIVO HCM of GS-5086 in RSV for Gilead Sciences
Thu, 21 Aug 2014 06:19:33 GMT
noodls – For immediate release 07.00: 21 August 2014 RETROSCREEN VIROLOGY GROUP PLC (“Retroscreen” or the “Company”) RETROSCREEN ANNOUNCES RESULTS FROM hVIVO VIRAL CHALLENGE STUDY ON RESPIRATORY …
The New All-Time Highs…
Wed, 20 Aug 2014 21:30:00 GMT
Gilead Sciences: ‘Risk of HCV Price War Overblown,' Bernstein Says
Wed, 20 Aug 2014 14:24:00 GMT
Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus
Wed, 20 Aug 2014 14:08:39 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook